<i>KRAS</i> and <i>BRAF</i> Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?

<div>Immunohistochemical analysis of<i> KRAS</i> wild-type colorectal cancer with positive staining, ×200 HPF.</div>

Gastroenterology Research and Practice

Figure 3: <i>KRAS</i> and <i>BRAF</i> Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer? 